Developer docs
API playgroundTry for free, no card

Search company profiles

PharSafer

Full company profile

uuid0009dpb

Namestring
PharSafer
Legal namestring
PharSafer Associates Limited
Websiteurl
pharsafer.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

PharSafer Associates Limited is a privately held specialist Contract Research Organisation (CRO) founded in 2003 by Dr. Graeme Ladds and headquartered in Ripley, Surrey, UK. The company delivers end-to-end pharmacovigilance and medical services to pharmaceutical, biotech, ATMP, medical device, and cosmetics organisations across 130+ countries, operating as an outsourced drug safety department for its clients. Its service portfolio spans six departments — Pharmacovigilance, Regulatory Strategy, SaPhar Training, White Gloves Audit Group, Medical Affairs, and Informatics — covering ICSR processing, aggregate reporting, signal detection, risk management, regulatory submissions, GCP/GPvP auditing, medical information, and database management.

The technology backbone is R.A.P.T.A.R., a proprietary safety automation and workflow platform comprising Reader, Clinical, and Reporting modules that support compliant, inspection-ready case processing for drugs, devices, vaccines, cosmetics, and drug-device combinations. Cumulative operating scale includes 750,000+ processed cases, 175+ audits, 97-99% case accuracy, and a validated global safety database. The company is wholly founder-owned (no external institutional investors disclosed), employs 101-250 people, and operates from the UK, India, Spain, and a remote US sales presence.

Revenue is generated exclusively through bespoke enterprise professional services engagements, with pricing not publicly disclosed. PharSafer pursues enterprise clients through dedicated New Business Managers in India and the US, RFP submission, introductory meetings, and conference-led thought leadership (BIO, DIA, World Drug Safety Congress). The company claims majority of clients have been retained 10+ years and 70% of clients reside outside the UK, indicating international revenue diversification and sticky, long-tail relationships.

Short descriptiontext

PharSafer is a UK-founded specialist CRO providing end-to-end pharmacovigilance, regulatory strategy, auditing, and medical affairs services to pharmaceutical, biotech, ATMP, device, and cosmetics clients across 130+ countries via its proprietary R.A.P.T.A.R. automation platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersRipley, United Kingdom
HQ citystring
Ripley
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacovigilance services, drug safety reporting, regulatory strategy consulting, clinical safety operations, pharmacovigilance auditing
Industry5 codes
PRIMARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
NAICS code1 code
  • Scientific Research and Development Services5417
Product category
Pharmacovigilance and Drug Safety Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Pharmacovigilance Services
TypeProfessional Services
Description

Full-service pharmacovigilance operations including case processing, ICSR submissions, literature review, signal detection, and aggregate reporting. Services are delivered as a complete outsourced pharmacovigilance department for clients.

pharsafer.com
2Regulatory Strategy Services
TypeProfessional Services
Description

Strategic consulting for license submissions, scientific advice, and regulatory pathway optimization across global markets including EU, UK, US, and emerging regions.

pharsafer.com
3Auditing Services
TypeProfessional Services
Description

GCP and GPvP auditing services including gap-fill analysis, pre-qualification assessments, and inspection readiness support through the White Gloves Audit Group.

pharsafer.com
4Medical Affairs Services
TypeProfessional Services
Description

Medical information services, safety communications, and medical review support for pharmaceutical and biotech products.

pharsafer.com
5Training Services (SaPhar)
TypeProfessional Services
Description

Industry training services delivered through sister company SaPhar for pharmacovigilance and clinical professionals, including new training courses and certification programs.

pharsafer.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1RAPTAR®
Description

Proprietary pharmacovigilance reporting and automation platform supporting compliant, inspection-ready safety processes.

pharsafer.com
+2 more records
Core offering1 text field

PharSafer is a specialist Contract Research Organisation (CRO) that delivers full-service pharmacovigilance and medical services, including ICSR processing, aggregate reporting, signal detection, risk management plans, regulatory strategy, auditing, medical affairs, informatics, and industry training. Service delivery is enabled by R.A.P.T.A.R., a proprietary safety automation and workflow platform, supported by a validated global safety database and 24/5 operations across the UK, India, and Spain for clinical and post-marketing drug safety.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 97-99% case accuracy and compliance achieved on all cases
+3 more records
Product overview1 text field

PharSafer® is a specialist Contract Research Organisation (CRO) offering Global Clinical and Post Marketing Drug Safety and Medical Services through a multi-department structure. The core product is R.A.P.T.A.R.® — a proprietary safety automation and workflow platform supporting compliant, inspection-ready case processing across drugs, devices, vaccines, cosmetics, and drug-device combinations. R.A.P.T.A.R.® Reader and R.A.P.T.A.R.® Clinical are sub-modules of this platform. These technology offerings are complemented by six service departments: Pharmacovigilance Services (ICSR processing, aggregate reporting, signal detection), Regulatory Strategy, SaPhar Training, White Gloves Audit Group, Medical Affairs, and Informatics. Together, the R.A.P.T.A.R.® platform and service departments enable PharSafer to operate as a client's complete Pharmacovigilance & Medical Services department.

Product and service7 records
1R.A.P.T.A.R. (Reporting, Analysis, Pharmacovigilance Tracking, Automation & Reporting)
CategorySafety Automation Software Platform
Description

A proprietary safety automation and workflow platform supporting compliant, inspection-ready pharmacovigilance case processing, signal detection, and adverse event reporting across drugs, devices, vaccines, cosmetics, and drug-device combinations. Includes the Reporting, Clinical, and Reader modules with access controls, auditability, workflow structures supporting data minimisation, and secure handling of safety data.

2Pharmacovigilance Services
CategoryPharmacovigilance Services
Description

Full-service pharmacovigilance support including ICSR processing, literature review, aggregate reporting (PSURs/PBRERs/DSURs), signal detection, risk management plans (RMPs/REMs), safety narrative generation, SOP writing, and case quality assurance for clinical and post-marketing phases. Delivered as a complete outsourced pharmacovigilance department for pharmaceutical, biotech, medical device, and cosmetics clients.

3Regulatory Strategy
CategoryRegulatory Consulting
Description

Strategic regulatory consulting covering clinical data submissions, license applications, scientific advice, and compliance pathway optimisation across global markets including the EU, UK, US, and emerging regions.

4SaPhar Training
CategoryIndustry Training
Description

Industry-focused pharmacovigilance and clinical training programs delivered by PharSafer's sister company SaPhar, serving as the training platform for all PharSafer employee and client training on pharmacovigilance and clinical topics.

5White Gloves Audit Group
CategoryAudit and Inspection Services
Description

Specialist auditing services including GCP and GPvP audits, gap-fill analysis, pre-qualification assessments, and inspection readiness support to help clients prepare for regulatory inspections.

6Medical Affairs
CategoryMedical Affairs Services
Description

Medical information services, safety communications, medical review, and scientific support for effective and proper product usage communication for pharmaceutical and biotech clients.

7Informatics
CategorySafety Database and Informatics Services
Description

Pharmacovigilance database management, safety database migration, ICSR processing tools, and systems support for global patient safety operations.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large full-service CRO with established post-marketing pharmacovigilance capabilities post-PRA Health Sciences acquisition. Competes with PharSafer in mid-to-large pharma PV outsourcing.

TypeDirect peer
Description

Regulatory affairs and pharmacovigilance services provider with strong European footprint. Comparable to PharSafer in PV/regulatory focus and similar mid-tier client segment.

TypeBroad incumbent
Description

Global full-service CRO with significant pharmacovigilance and regulatory services. Represents the broader incumbent alternative to PharSafer's specialist positioning.

TypeDirect peer
Description

Specialist pharmacovigilance CRO offering case processing, signal management, and aggregate reporting to pharma/biotech. Closest direct competitor to PharSafer in the dedicated mid-size PV services segment.

TypeDirect peer
Description

Specialized CRO with both clinical research and pharmacovigilance service lines. Direct overlap with PharSafer on the PV side, with additional clinical CRO breadth.

TypeDirect peer
Description

Drug safety, regulatory affairs, and quality/compliance consultancy serving pharma and biotech with similar mid-size CRO economics. Comparable in service mix and target customer profile.

7Navitas Life Sciences
TypeDirect peer
Description

Pharmacovigilance and regulatory services provider with global delivery capability. Overlaps with PharSafer on PV case processing, aggregate reporting, and safety database services.

TypeBroad incumbent
Description

Largest global CRO with comprehensive pharmacovigilance offerings as part of its broader life sciences services. Competes with PharSafer for enterprise pharma PV contracts at the high end.

TypeDirect peer
Description

Provides pharmacovigilance, regulatory affairs, and compliance consulting to pharma, biotech, and medical device companies. Overlaps directly with PharSafer's PV, regulatory strategy, and auditing offerings.

TypeBroad incumbent
Description

Mid-to-large full-service CRO with established pharmacovigilance and medical affairs capabilities. Broader portfolio than PharSafer but competes for the same outsourced PV mandates.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PharSafer

Pharmacovigilance and Drug Safety Servicespharsafer.com

PharSafer is a UK-founded specialist CRO providing end-to-end pharmacovigilance, regulatory strategy, auditing, and medical affairs services to pharmaceutical, biotech, ATMP, device, and cosmetics clients across 130+ countries via its proprietary R.A.P.T.A.R. automation platform.

What PharSafer does

PharSafer Associates Limited is a privately held specialist Contract Research Organisation (CRO) founded in 2003 by Dr. Graeme Ladds and headquartered in Ripley, Surrey, UK. The company delivers end-to-end pharmacovigilance and medical services to pharmaceutical, biotech, ATMP, medical device, and cosmetics organisations across 130+ countries, operating as an outsourced drug safety department for its clients. Its service portfolio spans six departments — Pharmacovigilance, Regulatory Strategy, SaPhar Training, White Gloves Audit Group, Medical Affairs, and Informatics — covering ICSR processing, aggregate reporting, signal detection, risk management, regulatory submissions, GCP/GPvP auditing, medical information, and database management.

The technology backbone is R.A.P.T.A.R., a proprietary safety automation and workflow platform comprising Reader, Clinical, and Reporting modules that support compliant, inspection-ready case processing for drugs, devices, vaccines, cosmetics, and drug-device combinations. Cumulative operating scale includes 750,000+ processed cases, 175+ audits, 97-99% case accuracy, and a validated global safety database. The company is wholly founder-owned (no external institutional investors disclosed), employs 101-250 people, and operates from the UK, India, Spain, and a remote US sales presence.

Revenue is generated exclusively through bespoke enterprise professional services engagements, with pricing not publicly disclosed. PharSafer pursues enterprise clients through dedicated New Business Managers in India and the US, RFP submission, introductory meetings, and conference-led thought leadership (BIO, DIA, World Drug Safety Congress). The company claims majority of clients have been retained 10+ years and 70% of clients reside outside the UK, indicating international revenue diversification and sticky, long-tail relationships.

PharSafer firmographics

Firmographics
Name
PharSafer
Legal name
PharSafer Associates Limited
Website
https://pharsafer.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
51–100 employees
Short description
PharSafer is a UK-founded specialist CRO providing end-to-end pharmacovigilance, regulatory strategy, auditing, and medical affairs services to pharmaceutical, biotech, ATMP, device, and cosmetics clients across 130+ countries via its proprietary R.A.P.T.A.R. automation platform.
Ownership category
akta.pro rank

PharSafer industry classification

Industry
Product category
Pharmacovigilance and Drug Safety Services
NAICS
Scientific Research and Development Services (5417)
akta.pro industry
PRIMARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Keywords

  • Pharmacovigilance services
  • Drug safety reporting
  • Regulatory strategy consulting
  • Clinical safety operations
  • Pharmacovigilance auditing

Where PharSafer is headquartered

Location

Headquarters

HQ city
Ripley
HQ country
United Kingdom
HQ region
Europe

Offices4 records

Markets served

PharSafer business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmacovigilance Services: Full-service pharmacovigilance operations including case processing, ICSR submissions, literature review, signal detection, and aggregate reporting. Services are delivered as a complete outsourced pharmacovigilance department for clients.
  2. Regulatory Strategy Services: Strategic consulting for license submissions, scientific advice, and regulatory pathway optimization across global markets including EU, UK, US, and emerging regions.
  3. Auditing Services: GCP and GPvP auditing services including gap-fill analysis, pre-qualification assessments, and inspection readiness support through the White Gloves Audit Group.
  4. Medical Affairs Services: Medical information services, safety communications, and medical review support for pharmaceutical and biotech products.
  5. Training Services (SaPhar): Industry training services delivered through sister company SaPhar for pharmacovigilance and clinical professionals, including new training courses and certification programs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

PharSafer product offering

Product offering

Core offering

PharSafer is a specialist Contract Research Organisation (CRO) that delivers full-service pharmacovigilance and medical services, including ICSR processing, aggregate reporting, signal detection, risk management plans, regulatory strategy, auditing, medical affairs, informatics, and industry training. Service delivery is enabled by R.A.P.T.A.R., a proprietary safety automation and workflow platform, supported by a validated global safety database and 24/5 operations across the UK, India, and Spain for clinical and post-marketing drug safety.

Product overview

PharSafer® is a specialist Contract Research Organisation (CRO) offering Global Clinical and Post Marketing Drug Safety and Medical Services through a multi-department structure. The core product is R.A.P.T.A.R.® — a proprietary safety automation and workflow platform supporting compliant, inspection-ready case processing across drugs, devices, vaccines, cosmetics, and drug-device combinations. R.A.P.T.A.R.® Reader and R.A.P.T.A.R.® Clinical are sub-modules of this platform. These technology offerings are complemented by six service departments: Pharmacovigilance Services (ICSR processing, aggregate reporting, signal detection), Regulatory Strategy, SaPhar Training, White Gloves Audit Group, Medical Affairs, and Informatics. Together, the R.A.P.T.A.R.® platform and service departments enable PharSafer to operate as a client's complete Pharmacovigilance & Medical Services department.

Differentiator

Problem solved

Functional benefit

Brands

  • RAPTAR®: Proprietary pharmacovigilance reporting and automation platform supporting compliant, inspection-ready safety processes.
  • SaPhar
  • White Gloves Audit Group

Products and services

  • R.A.P.T.A.R. (Reporting, Analysis, Pharmacovigilance Tracking, Automation & Reporting) A proprietary safety automation and workflow platform supporting compliant, inspection-ready pharmacovigilance case processing, signal detection, and adverse event reporting across drugs, devices, vaccines, cosmetics, and drug-device combinations. Includes the Reporting, Clinical, and Reader modules with access controls, auditability, workflow structures supporting data minimisation, and secure handling of safety data.
  • Pharmacovigilance Services Full-service pharmacovigilance support including ICSR processing, literature review, aggregate reporting (PSURs/PBRERs/DSURs), signal detection, risk management plans (RMPs/REMs), safety narrative generation, SOP writing, and case quality assurance for clinical and post-marketing phases. Delivered as a complete outsourced pharmacovigilance department for pharmaceutical, biotech, medical device, and cosmetics clients.
  • Regulatory Strategy Strategic regulatory consulting covering clinical data submissions, license applications, scientific advice, and compliance pathway optimisation across global markets including the EU, UK, US, and emerging regions.
  • SaPhar Training Industry-focused pharmacovigilance and clinical training programs delivered by PharSafer's sister company SaPhar, serving as the training platform for all PharSafer employee and client training on pharmacovigilance and clinical topics.
  • White Gloves Audit Group Specialist auditing services including GCP and GPvP audits, gap-fill analysis, pre-qualification assessments, and inspection readiness support to help clients prepare for regulatory inspections.
  • Medical Affairs Medical information services, safety communications, medical review, and scientific support for effective and proper product usage communication for pharmaceutical and biotech clients.
  • Informatics Pharmacovigilance database management, safety database migration, ICSR processing tools, and systems support for global patient safety operations.

Quantifiable outcome

  • 97-99% case accuracy and compliance achieved on all cases
  • +3 more outcomes

Companies that use PharSafer

Customer profile

Segments5 records

Ideal customer profiles4 records

PharSafer technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

PharSafer partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves8 records

Expansion highlights5 records

PharSafer competitors and assessment

Company assessment

Broad incumbents

  • ICON plc: Large full-service CRO with established post-marketing pharmacovigilance capabilities post-PRA Health Sciences acquisition. Competes with PharSafer in mid-to-large pharma PV outsourcing.
  • Parexel International: Global full-service CRO with significant pharmacovigilance and regulatory services. Represents the broader incumbent alternative to PharSafer's specialist positioning.
  • IQVIA: Largest global CRO with comprehensive pharmacovigilance offerings as part of its broader life sciences services. Competes with PharSafer for enterprise pharma PV contracts at the high end.
  • Worldwide Clinical Trials: Mid-to-large full-service CRO with established pharmacovigilance and medical affairs capabilities. Broader portfolio than PharSafer but competes for the same outsourced PV mandates.

Direct peers

  • Pharmalex: Regulatory affairs and pharmacovigilance services provider with strong European footprint. Comparable to PharSafer in PV/regulatory focus and similar mid-tier client segment.
  • PrimeVigilance: Specialist pharmacovigilance CRO offering case processing, signal management, and aggregate reporting to pharma/biotech. Closest direct competitor to PharSafer in the dedicated mid-size PV services segment.
  • Ergomed plc: Specialized CRO with both clinical research and pharmacovigilance service lines. Direct overlap with PharSafer on the PV side, with additional clinical CRO breadth.
  • Arriello: Drug safety, regulatory affairs, and quality/compliance consultancy serving pharma and biotech with similar mid-size CRO economics. Comparable in service mix and target customer profile.
  • Navitas Life Sciences: Pharmacovigilance and regulatory services provider with global delivery capability. Overlaps with PharSafer on PV case processing, aggregate reporting, and safety database services.
  • ProPharma Group: Provides pharmacovigilance, regulatory affairs, and compliance consulting to pharma, biotech, and medical device companies. Overlaps directly with PharSafer's PV, regulatory strategy, and auditing offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

PharSafer social profiles

Digital presence

PharSafer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PharSafer leadership team

Management profile

Number of profiles

Profiles1 record

PharSafer subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

PharSafer funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PharSafer M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharSafer

What does PharSafer do?

PharSafer is a specialist Contract Research Organisation (CRO) that delivers full-service pharmacovigilance and medical services, including ICSR processing, aggregate reporting, signal detection, risk management plans, regulatory strategy, auditing, medical affairs, informatics, and industry training. Service delivery is enabled by R.A.P.T.A.R., a proprietary safety automation and workflow platform, supported by a validated global safety database and 24/5 operations across the UK, India, and Spain for clinical and post-marketing drug safety.

Is PharSafer a public or private company?

PharSafer is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was PharSafer founded?

PharSafer was founded in 2003. It employs 51 to 100 people.

Where is PharSafer based?

PharSafer is headquartered in Ripley, United Kingdom, in the Europe region.

How does PharSafer make money?

Five revenue lines are on record. Pharmacovigilance Services are the primary driver. The others are regulatory Strategy Services, auditing Services, medical Affairs Services and training Services (SaPhar).

Who are PharSafer's main competitors?

Broad incumbents on record are ICON plc, Parexel International, IQVIA and Worldwide Clinical Trials. Direct peers are Pharmalex, PrimeVigilance, Ergomed plc, Arriello, Navitas Life Sciences and ProPharma Group.

Does PharSafer have an API?

No public API is recorded for PharSafer.

What industry is PharSafer in?

PharSafer's product category is Pharmacovigilance and Drug Safety Services. Its primary akta.pro industry code is HLAGAAAH, Pharmacovigilance, Risk Management & Medical Affairs CROs, with a secondary code of HLAGAAAG, Medical Writing & Regulatory Submission Support CROs. Its NAICS code is 5417.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SiliconindiaIndia PV Community Unites at the 6th DSS 2026The 6th Edition Drug Safety Symposium 2026 – India Chapter, organized by Eminence Business Media, concluded successfully in Mumbai, bringing together senior leaders from pharmaceutical companies, CROs, regulatory bodies, technology organizations, and healthcare institutions to discuss pharmacovigilance, drug safety, and patient safety. The two-day symposium featured expert sessions on AI, automation, regulatory transformation, signal management, and FDA inspection readiness, with a keynote address by Dr. Nilima Kshirsagar and a leadership panel on the future of pharmacovigilance operating models. Industry partners including PharSafer, Pivot Path, Techsol, SafeVig Solutions, and others supported the event, which is part of a global series with upcoming editions planned for the Middle East, Canada, and India.GlobeNewswireSignal Detection and Regulatory Expectations: 2-Day Online Training Course (September 30, 2026 and Oct 1, 2026) with 12 CPD HoursResearchAndMarkets.com added a two-day online training course on signal detection and regulatory expectations for September 30 and October 1, 2026. The course covers Module IX signal management, RMP/REMS links, and quantitative assessments, offering 12 CPD hours. It targets pharmacovigilance and regulatory staff.GlobeNewswire2-Day Medical Device Studies Training Course: Regulatory Requirements and Adverse Event Reporting (Online: Sept 17th-18th, 2026)ResearchAndMarkets.com added a two-day online training course on medical device regulatory requirements and adverse event reporting, scheduled for September 17-18, 2026. The course covers clinical evaluations, investigations, and PMCF studies under the new Medical Device Regulations (MDR), with 12 CPD hours accredited. It also addresses post-Brexit implications for EU and UK device management.GlobeNewswire5-Day Advanced Pharmacovigilance Training Course: From Performing Successful Due Diligence to Benefit-Risk Assessments - What to Consider (Sept 21st-25th, 2026)ResearchAndMarkets.com has announced a 5-day Advanced Pharmacovigilance training course scheduled for September 21st-25th, 2026, designed for professionals with at least two years of drug safety experience. The course will cover topics including audits and inspections, compliance requirements, product safety reviews, safety reporting in licensing agreements, risk-benefit determinations, and risk management plans. Graeme Ladds, Director of PharSafer Associates Ltd with over 30 years of pharmaceutical industry experience, will serve as the speaker for the course.GlobeNewswireAdvanced Pharmacovigilance Online Training Course: From Performing Successful Due Diligence to Benefit-Risk Assessments and What to Consider (Sept 21st - Sept 25th, 2026)ResearchAndMarkets.com added an online training course on advanced pharmacovigilance, covering due diligence, audits, compliance, and risk-benefit assessments. The course runs September 21-25, 2026, and targets safety professionals with at least two years' experience. It includes interactive exercises and offers 18 CPD hours.GlobeNewswireProducing and Maintaining the Pharmacovigilance System Master File (PSMF) in the European Union Practical Training Course (ONLINE EVENT: Sept 16, 2026)ResearchAndMarkets.com added a practical training course on producing and maintaining the Pharmacovigilance System Master File (PSMF) in the EU, scheduled for September 16, 2026. The course covers regulatory requirements, inspection findings, and post-Brexit updates, offering 6 hours of CPD certification.PR NewswireOne Week Until Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors - Broadening your Knowledge Training Course (February 22-24, 2023)ResearchAndMarkets.com announced the addition of a three-day Pharmacovigilance training course covering drug safety, regulatory affairs, and PV auditing topics, scheduled for February 22-24, 2023. The course, to be led by Graeme Ladds of PharSafer Associates Ltd., will address global pharmacovigilance standards, adverse event reporting, EU and FDA regulations, medical device reporting, and safety monitoring across clinical and post-marketing phases. This appears to be a promotional/educational announcement for professional development rather than a news event.